As flu season approaches, it’s still not too late to get your flu shot.

Release date:

2017-10-24

Author:

Article/Excerpt by Qianxun Life & Health

Source:


Abstract

As soon as the temperature drops, influenza swiftly makes its way toward us. Following two consecutive days and nights of light rain, a sharp drop in temperatures has set in, and many people, unaccustomed to such abrupt weather changes, have already begun battling the flu virus. With winter approaching, the seasonal flu peak is also just around the corner; starting in September each year, regions across the country gradually enter the high‑incidence period for influenza. Staying clear of the flu virus and scientifically and effectively protecting yourself and your family from infection has once again become a top priority. In fact, influenza itself is not frightening, but it can lead to serious complications, such as myocarditis, viral encephalitis, viral pneumonia, and more.

  As soon as the temperature drops, the flu quickly makes its way to us. Following two days and two nights of steady light rain, a sharp drop in temperatures has set in, and many people, unaccustomed to such sudden weather changes, have already begun battling the flu virus.

 

 

  As winter approaches, the seasonal flu peak is also just around the corner. Starting in September each year, regions across the country gradually enter the high-incidence period for influenza. Staying clear of the flu virus and adopting scientifically sound measures to protect yourself and your family from infection has once again become a top priority.

  In fact, influenza itself is not frightening, but it can lead to serious complications, such as myocarditis, viral encephalitis, and viral pneumonia. The culprit behind influenza is the influenza virus, which spreads primarily through respiratory droplets. Infectiousness is highest in the early stages of illness; when patients speak, cough, or sneeze, they release the virus into the air, and others may become infected by inadvertently inhaling these tiny virus‑laden droplets.

  In addition, direct contact is another mode of transmission. For example, if a person with influenza touches a doorknob with the hand that covered their cough or sneeze, a healthy individual may become infected by touching that same doorknob and then rubbing their nose or eyes. This risk is particularly high in crowded settings such as kindergartens and schools, where children can easily contract influenza through inadvertent contact. To protect yourself during the winter and spring seasons when influenza viruses are rampant, prevention is far more effective than treatment.

  Compared with handwashing—which prevents the virus from entering the body via contact with the mouth or eyes—and with measures such as diet and exercise to boost immunity, vaccination is the most targeted and effective intervention. The influenza vaccine can provide comprehensive protection against influenza for people of all age groups.

  Many people worry about the safety of the influenza vaccine. The influenza vaccine is produced by cultivating influenza viruses in chicken embryo protein cultures and then inactivating them with chemical agents, leaving only the antigenic components without any viral activity; thus, it is a very safe vaccine.

 

 

  The influenza virus evolves annually, and the flu vaccine is updated each year to match these changes and enhance protection; therefore, annual vaccination is recommended. It typically takes 7 to 15 days after receiving the flu shot for protective antibodies to develop, so the optimal time for vaccination is about two weeks before the onset of a major flu season. If you become infected with the influenza virus shortly after vaccination, your body may not yet have produced sufficient antibodies, leaving you at risk of contracting the flu. In China, the most suitable period for getting vaccinated is from September to December.

  For older adults, individuals with chronic illnesses, and infants aged 0–6 months, immune defenses are weaker than those of younger, healthier adults. Once infected with the influenza virus, these groups typically experience more severe illness, have a higher risk of developing pneumonia, and are more likely to develop complications affecting other organ systems. Therefore, they should be prioritized for vaccination. Effective vaccination can substantially reduce the risk of serious influenza‑related complications, hospitalization, and death.

  At present, all influenza vaccines available in China are trivalent inactivated influenza vaccines, which provide multi‑faceted protection against infection by the corresponding influenza virus subtypes. However, individuals with allergies to eggs or to any component of the vaccine should not receive it. Persons with mild to moderate acute illnesses, whether or not accompanied by fever, should postpone vaccination until their symptoms have resolved.

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09